ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 130 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $10,000 | +11.1% | 399 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $9,000 | -80.9% | 399 | -75.0% | 0.00% | -71.4% |
Q1 2016 | $47,000 | -11.3% | 1,599 | 0.0% | 0.01% | -30.0% |
Q4 2015 | $53,000 | -13.1% | 1,599 | 0.0% | 0.01% | -9.1% |
Q3 2015 | $61,000 | -47.9% | 1,599 | -38.5% | 0.01% | -45.0% |
Q2 2015 | $117,000 | +875.0% | 2,599 | +551.4% | 0.02% | +900.0% |
Q1 2015 | $12,000 | – | 399 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |